Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Smoking Cessation | 19 | 2025 | 2085 | 3.270 |
Why?
|
Substance-Related Disorders | 26 | 2025 | 4423 | 2.340 |
Why?
|
Alcoholism | 13 | 2023 | 1981 | 1.970 |
Why?
|
Alcohol-Related Disorders | 6 | 2020 | 243 | 1.610 |
Why?
|
Self Efficacy | 12 | 2019 | 643 | 1.410 |
Why?
|
Alcoholics Anonymous | 6 | 2014 | 32 | 1.230 |
Why?
|
Self-Help Groups | 9 | 2025 | 194 | 1.200 |
Why?
|
Alcohol Drinking | 8 | 2017 | 4045 | 1.120 |
Why?
|
Tobacco Use Disorder | 5 | 2021 | 708 | 1.100 |
Why?
|
Smoking | 15 | 2022 | 9094 | 1.050 |
Why?
|
Opioid-Related Disorders | 11 | 2024 | 2188 | 0.910 |
Why?
|
Happiness | 4 | 2019 | 170 | 0.910 |
Why?
|
Ketamine | 7 | 2022 | 527 | 0.800 |
Why?
|
Temperance | 2 | 2012 | 88 | 0.790 |
Why?
|
Residential Treatment | 5 | 2015 | 112 | 0.680 |
Why?
|
Substance Abuse Treatment Centers | 2 | 2020 | 155 | 0.670 |
Why?
|
Students | 5 | 2014 | 1744 | 0.650 |
Why?
|
Behavior Therapy | 4 | 2023 | 886 | 0.600 |
Why?
|
Health Behavior | 5 | 2022 | 2649 | 0.600 |
Why?
|
Motivation | 8 | 2022 | 2025 | 0.590 |
Why?
|
Universities | 5 | 2014 | 1005 | 0.570 |
Why?
|
Smiling | 1 | 2017 | 72 | 0.550 |
Why?
|
Employment | 2 | 2020 | 1114 | 0.530 |
Why?
|
Community Health Centers | 1 | 2020 | 469 | 0.520 |
Why?
|
Bipolar Disorder | 6 | 2019 | 5131 | 0.510 |
Why?
|
Pharmaceutical Preparations | 2 | 2020 | 1088 | 0.480 |
Why?
|
Buprenorphine | 6 | 2022 | 667 | 0.470 |
Why?
|
Quality of Life | 6 | 2023 | 13510 | 0.450 |
Why?
|
National Institute on Alcohol Abuse and Alcoholism (U.S.) | 1 | 2013 | 10 | 0.440 |
Why?
|
Behavior, Addictive | 4 | 2015 | 428 | 0.430 |
Why?
|
Self Care | 1 | 2019 | 801 | 0.430 |
Why?
|
Depressive Disorder, Major | 8 | 2022 | 4818 | 0.420 |
Why?
|
Social Support | 7 | 2021 | 2193 | 0.420 |
Why?
|
Female | 87 | 2025 | 397515 | 0.420 |
Why?
|
Adult | 57 | 2025 | 223851 | 0.400 |
Why?
|
Mood Disorders | 1 | 2019 | 1129 | 0.400 |
Why?
|
Psychiatric Status Rating Scales | 6 | 2021 | 6030 | 0.400 |
Why?
|
Male | 77 | 2025 | 365203 | 0.390 |
Why?
|
Psychotherapy | 2 | 2019 | 1654 | 0.390 |
Why?
|
Counseling | 2 | 2019 | 1554 | 0.390 |
Why?
|
Feasibility Studies | 6 | 2024 | 5323 | 0.390 |
Why?
|
Opiate Substitution Treatment | 4 | 2022 | 452 | 0.370 |
Why?
|
Risk-Taking | 3 | 2014 | 1023 | 0.350 |
Why?
|
Models, Psychological | 4 | 2014 | 826 | 0.340 |
Why?
|
Humans | 103 | 2025 | 768970 | 0.340 |
Why?
|
Internet | 5 | 2019 | 3112 | 0.340 |
Why?
|
Public Health | 2 | 2021 | 2680 | 0.340 |
Why?
|
New England | 4 | 2024 | 1058 | 0.330 |
Why?
|
Middle Aged | 44 | 2025 | 223737 | 0.330 |
Why?
|
Self Disclosure | 1 | 2010 | 248 | 0.330 |
Why?
|
Psychometrics | 6 | 2022 | 3066 | 0.320 |
Why?
|
Adolescent Development | 1 | 2012 | 279 | 0.320 |
Why?
|
Methadone | 5 | 2023 | 317 | 0.310 |
Why?
|
Young Adult | 30 | 2024 | 60131 | 0.290 |
Why?
|
Sex Characteristics | 2 | 2019 | 2649 | 0.280 |
Why?
|
Suicide | 2 | 2017 | 1606 | 0.280 |
Why?
|
Affect | 1 | 2014 | 1500 | 0.270 |
Why?
|
Periodicity | 1 | 2007 | 348 | 0.260 |
Why?
|
Adolescent Behavior | 4 | 2014 | 1188 | 0.250 |
Why?
|
Depression | 6 | 2023 | 8231 | 0.250 |
Why?
|
United States | 16 | 2025 | 73186 | 0.250 |
Why?
|
Longitudinal Studies | 10 | 2023 | 14794 | 0.250 |
Why?
|
Adolescent | 32 | 2019 | 89244 | 0.240 |
Why?
|
Treatment Outcome | 26 | 2022 | 65480 | 0.220 |
Why?
|
Interviews as Topic | 2 | 2011 | 2744 | 0.220 |
Why?
|
Self Concept | 2 | 2020 | 1046 | 0.220 |
Why?
|
Aminopyridines | 2 | 2019 | 580 | 0.220 |
Why?
|
Guideline Adherence | 1 | 2013 | 2241 | 0.210 |
Why?
|
Interpersonal Relations | 4 | 2015 | 1437 | 0.200 |
Why?
|
Cross-Sectional Studies | 7 | 2024 | 26395 | 0.200 |
Why?
|
Narcotic Antagonists | 2 | 2020 | 591 | 0.200 |
Why?
|
Peer Group | 2 | 2020 | 698 | 0.200 |
Why?
|
Heterosexuality | 1 | 2024 | 309 | 0.190 |
Why?
|
Recurrence | 6 | 2019 | 8513 | 0.190 |
Why?
|
Decision Making | 2 | 2013 | 3953 | 0.190 |
Why?
|
Infusions, Intravenous | 6 | 2022 | 2231 | 0.190 |
Why?
|
Social Work | 1 | 2023 | 158 | 0.190 |
Why?
|
Telephone | 1 | 2025 | 630 | 0.190 |
Why?
|
Antidepressive Agents | 4 | 2022 | 2913 | 0.170 |
Why?
|
Medication Adherence | 2 | 2022 | 2192 | 0.170 |
Why?
|
Yoga | 1 | 2023 | 280 | 0.170 |
Why?
|
Prospective Studies | 11 | 2021 | 54962 | 0.170 |
Why?
|
Behavioral Medicine | 1 | 2020 | 49 | 0.170 |
Why?
|
Dementia | 2 | 2024 | 2741 | 0.160 |
Why?
|
Focus Groups | 2 | 2024 | 1462 | 0.160 |
Why?
|
Nitroprusside | 1 | 2019 | 272 | 0.160 |
Why?
|
Cohort Effect | 1 | 2018 | 39 | 0.160 |
Why?
|
Marijuana Abuse | 1 | 2023 | 409 | 0.160 |
Why?
|
Receptors, Opioid, kappa | 1 | 2020 | 136 | 0.160 |
Why?
|
Pregnancy Complications | 3 | 2024 | 2974 | 0.160 |
Why?
|
Risk Assessment | 2 | 2017 | 24333 | 0.150 |
Why?
|
Unemployment | 1 | 2020 | 211 | 0.150 |
Why?
|
Risk Reduction Behavior | 1 | 2024 | 1119 | 0.150 |
Why?
|
Pyrrolidines | 1 | 2020 | 341 | 0.150 |
Why?
|
Double-Blind Method | 10 | 2022 | 12467 | 0.150 |
Why?
|
Magnetic Field Therapy | 1 | 2017 | 27 | 0.140 |
Why?
|
Cohort Studies | 6 | 2023 | 41808 | 0.140 |
Why?
|
Reproducibility of Results | 6 | 2017 | 20245 | 0.140 |
Why?
|
Mental Disorders | 5 | 2024 | 6876 | 0.140 |
Why?
|
Cannabis | 1 | 2023 | 446 | 0.140 |
Why?
|
Self Report | 2 | 2019 | 3773 | 0.140 |
Why?
|
Piperazines | 2 | 2019 | 2553 | 0.140 |
Why?
|
Pilot Projects | 5 | 2024 | 8748 | 0.130 |
Why?
|
Harm Reduction | 1 | 2017 | 143 | 0.130 |
Why?
|
Health Surveys | 2 | 2018 | 4055 | 0.120 |
Why?
|
Midazolam | 3 | 2022 | 267 | 0.120 |
Why?
|
Telemedicine | 3 | 2024 | 3110 | 0.120 |
Why?
|
Patient Acceptance of Health Care | 5 | 2024 | 3235 | 0.120 |
Why?
|
Nicotinic Agonists | 1 | 2016 | 265 | 0.120 |
Why?
|
Premenopause | 1 | 2019 | 1039 | 0.120 |
Why?
|
HIV Infections | 4 | 2024 | 17591 | 0.120 |
Why?
|
Mental Health Services | 2 | 2018 | 1732 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2024 | 10400 | 0.110 |
Why?
|
Benzamides | 1 | 2020 | 1387 | 0.110 |
Why?
|
Clergy | 1 | 2015 | 79 | 0.110 |
Why?
|
Postpartum Period | 1 | 2021 | 1198 | 0.110 |
Why?
|
Prevalence | 4 | 2018 | 15879 | 0.110 |
Why?
|
Critical Pathways | 1 | 2017 | 476 | 0.110 |
Why?
|
Analgesics, Opioid | 3 | 2022 | 3838 | 0.110 |
Why?
|
Religion and Medicine | 1 | 2015 | 161 | 0.110 |
Why?
|
Analysis of Variance | 3 | 2015 | 6236 | 0.110 |
Why?
|
Propranolol | 1 | 2014 | 493 | 0.100 |
Why?
|
Mothers | 1 | 2023 | 2209 | 0.100 |
Why?
|
Negotiating | 1 | 2014 | 152 | 0.100 |
Why?
|
Qualitative Research | 1 | 2024 | 3143 | 0.100 |
Why?
|
Psychiatric Department, Hospital | 1 | 2013 | 133 | 0.100 |
Why?
|
Factor Analysis, Statistical | 2 | 2012 | 1002 | 0.100 |
Why?
|
Benzodiazepines | 2 | 2022 | 1138 | 0.100 |
Why?
|
Socioeconomic Factors | 5 | 2019 | 7861 | 0.100 |
Why?
|
Condoms | 1 | 2014 | 338 | 0.100 |
Why?
|
Follow-Up Studies | 9 | 2017 | 39394 | 0.100 |
Why?
|
Electronics | 1 | 2013 | 317 | 0.100 |
Why?
|
Professional Competence | 1 | 2015 | 430 | 0.100 |
Why?
|
Anxiety Disorders | 2 | 2023 | 2749 | 0.090 |
Why?
|
Suicidal Ideation | 2 | 2021 | 1462 | 0.090 |
Why?
|
Fluoxetine | 1 | 2015 | 733 | 0.090 |
Why?
|
Computer-Assisted Instruction | 1 | 2014 | 366 | 0.090 |
Why?
|
Directive Counseling | 1 | 2011 | 171 | 0.090 |
Why?
|
Computer Simulation | 3 | 2015 | 6291 | 0.080 |
Why?
|
Postmenopause | 1 | 2019 | 2519 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2016 | 4056 | 0.080 |
Why?
|
Office Visits | 1 | 2013 | 596 | 0.080 |
Why?
|
Schizophrenia | 2 | 2019 | 6987 | 0.080 |
Why?
|
Medical Staff, Hospital | 1 | 2013 | 603 | 0.080 |
Why?
|
Patient Participation | 1 | 2018 | 1448 | 0.080 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 937 | 0.080 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2014 | 1243 | 0.080 |
Why?
|
Age Factors | 6 | 2014 | 18435 | 0.080 |
Why?
|
Severity of Illness Index | 4 | 2015 | 15951 | 0.080 |
Why?
|
Healthcare Disparities | 2 | 2024 | 3421 | 0.080 |
Why?
|
Education, Medical, Continuing | 1 | 2014 | 829 | 0.080 |
Why?
|
Combined Modality Therapy | 2 | 2017 | 8559 | 0.080 |
Why?
|
Pregnancy | 7 | 2024 | 30265 | 0.070 |
Why?
|
Emotions | 2 | 2023 | 2768 | 0.070 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1515 | 0.070 |
Why?
|
Arousal | 1 | 2014 | 1183 | 0.070 |
Why?
|
Minnesota | 1 | 2007 | 339 | 0.070 |
Why?
|
Health Services Needs and Demand | 1 | 2015 | 1407 | 0.070 |
Why?
|
Adaptation, Psychological | 3 | 2013 | 2666 | 0.070 |
Why?
|
Professional-Patient Relations | 1 | 2012 | 725 | 0.070 |
Why?
|
Community Health Services | 1 | 2011 | 659 | 0.070 |
Why?
|
Health Personnel | 2 | 2024 | 3383 | 0.070 |
Why?
|
Seasons | 1 | 2012 | 1524 | 0.070 |
Why?
|
Ambulatory Care | 2 | 2014 | 2784 | 0.060 |
Why?
|
Antipsychotic Agents | 1 | 2019 | 3081 | 0.060 |
Why?
|
Exercise | 1 | 2022 | 5954 | 0.060 |
Why?
|
Cluster Analysis | 1 | 2012 | 2732 | 0.060 |
Why?
|
Aged | 13 | 2024 | 171786 | 0.060 |
Why?
|
Christianity | 1 | 2025 | 53 | 0.060 |
Why?
|
Delivery of Health Care | 2 | 2023 | 5375 | 0.060 |
Why?
|
Medicare | 1 | 2023 | 6888 | 0.060 |
Why?
|
Diet | 1 | 2022 | 8088 | 0.060 |
Why?
|
Patient Discharge | 1 | 2017 | 3491 | 0.060 |
Why?
|
Learning | 1 | 2014 | 1760 | 0.060 |
Why?
|
Urban Population | 1 | 2012 | 2046 | 0.060 |
Why?
|
Anxiety | 1 | 2018 | 4672 | 0.050 |
Why?
|
Diagnosis, Dual (Psychiatry) | 2 | 2013 | 300 | 0.050 |
Why?
|
Risk Factors | 4 | 2018 | 74976 | 0.050 |
Why?
|
Life Style | 2 | 2024 | 3931 | 0.050 |
Why?
|
Massachusetts | 3 | 2024 | 8894 | 0.050 |
Why?
|
Social Behavior | 1 | 2009 | 1146 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15471 | 0.050 |
Why?
|
Health Promotion | 1 | 2014 | 2210 | 0.050 |
Why?
|
Hepatitis C | 1 | 2011 | 1595 | 0.050 |
Why?
|
Retrospective Studies | 6 | 2023 | 81903 | 0.050 |
Why?
|
Veterans | 1 | 2015 | 2672 | 0.050 |
Why?
|
Models, Theoretical | 1 | 2012 | 3580 | 0.040 |
Why?
|
Outpatients | 2 | 2019 | 1603 | 0.040 |
Why?
|
Personal Satisfaction | 1 | 2024 | 645 | 0.040 |
Why?
|
Child | 7 | 2023 | 80960 | 0.040 |
Why?
|
Patient Compliance | 3 | 2014 | 2701 | 0.040 |
Why?
|
Empathy | 1 | 2023 | 476 | 0.040 |
Why?
|
Sex Factors | 1 | 2012 | 10633 | 0.040 |
Why?
|
Primary Myelofibrosis | 2 | 1990 | 209 | 0.040 |
Why?
|
Parenting | 1 | 2023 | 709 | 0.040 |
Why?
|
Social Stigma | 1 | 2024 | 788 | 0.040 |
Why?
|
Individuality | 1 | 2019 | 307 | 0.040 |
Why?
|
Infant | 3 | 2023 | 36556 | 0.030 |
Why?
|
Stress, Psychological | 1 | 2012 | 4530 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10765 | 0.030 |
Why?
|
Clozapine | 1 | 2019 | 509 | 0.030 |
Why?
|
Sibling Relations | 1 | 2015 | 46 | 0.030 |
Why?
|
Attitude | 1 | 2020 | 772 | 0.030 |
Why?
|
Aging | 1 | 2014 | 8745 | 0.030 |
Why?
|
Random Allocation | 1 | 2019 | 2394 | 0.030 |
Why?
|
Biomarkers, Pharmacological | 1 | 2015 | 162 | 0.030 |
Why?
|
Data Interpretation, Statistical | 2 | 2015 | 2714 | 0.030 |
Why?
|
Linear Models | 2 | 2015 | 5891 | 0.030 |
Why?
|
Friends | 1 | 2015 | 148 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2019 | 59739 | 0.030 |
Why?
|
Time Factors | 2 | 2016 | 40261 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2024 | 2784 | 0.030 |
Why?
|
Fear | 1 | 2022 | 1493 | 0.030 |
Why?
|
Breast Feeding | 1 | 2021 | 1364 | 0.030 |
Why?
|
Galvanic Skin Response | 1 | 2014 | 359 | 0.030 |
Why?
|
Myeloproliferative Disorders | 2 | 1989 | 616 | 0.020 |
Why?
|
Accidents | 1 | 2013 | 164 | 0.020 |
Why?
|
Patient Dropouts | 1 | 2014 | 411 | 0.020 |
Why?
|
Community Mental Health Services | 1 | 2015 | 388 | 0.020 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2015 | 491 | 0.020 |
Why?
|
Reference Values | 1 | 2019 | 4940 | 0.020 |
Why?
|
Bone Marrow | 4 | 1990 | 2936 | 0.020 |
Why?
|
Substance Abuse Detection | 1 | 2014 | 301 | 0.020 |
Why?
|
Probability | 1 | 2016 | 2483 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6547 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2014 | 1586 | 0.020 |
Why?
|
Parent-Child Relations | 1 | 2015 | 773 | 0.020 |
Why?
|
Community-Institutional Relations | 1 | 2011 | 209 | 0.020 |
Why?
|
Time | 1 | 2011 | 552 | 0.020 |
Why?
|
Cues | 1 | 2014 | 878 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3904 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6320 | 0.020 |
Why?
|
Religion | 1 | 2011 | 376 | 0.020 |
Why?
|
Sexually Transmitted Diseases | 1 | 2014 | 668 | 0.020 |
Why?
|
Central Nervous System Depressants | 1 | 2009 | 163 | 0.020 |
Why?
|
Thrombocytosis | 1 | 1988 | 88 | 0.020 |
Why?
|
Spirituality | 1 | 2011 | 430 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12562 | 0.020 |
Why?
|
Bone Development | 1 | 1989 | 473 | 0.020 |
Why?
|
Heart Diseases | 1 | 2019 | 2819 | 0.020 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 1990 | 686 | 0.020 |
Why?
|
Osteoclasts | 1 | 1989 | 713 | 0.020 |
Why?
|
Age of Onset | 1 | 2012 | 3346 | 0.020 |
Why?
|
Aftercare | 1 | 2011 | 921 | 0.020 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2015 | 1106 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2011 | 1476 | 0.020 |
Why?
|
Health Policy | 1 | 2017 | 2700 | 0.020 |
Why?
|
Memory | 1 | 2014 | 2209 | 0.010 |
Why?
|
Health Education | 1 | 2011 | 1059 | 0.010 |
Why?
|
Hepacivirus | 1 | 2011 | 1344 | 0.010 |
Why?
|
Sexual Behavior | 1 | 2014 | 2200 | 0.010 |
Why?
|
Heart Rate | 1 | 2014 | 4217 | 0.010 |
Why?
|
Brain Injuries | 1 | 2015 | 2058 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8749 | 0.010 |
Why?
|
Ethanol | 1 | 2009 | 1331 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 2024 | 8760 | 0.010 |
Why?
|
Depressive Disorder | 1 | 2015 | 3723 | 0.010 |
Why?
|
Regression Analysis | 1 | 2011 | 6346 | 0.010 |
Why?
|
Biomedical Research | 1 | 2017 | 3463 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2015 | 3628 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 3709 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2022 | 26428 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2013 | 1947 | 0.010 |
Why?
|
Cognition | 1 | 2019 | 7081 | 0.010 |
Why?
|
Child, Preschool | 1 | 2023 | 42683 | 0.010 |
Why?
|
Models, Statistical | 1 | 2015 | 5110 | 0.010 |
Why?
|
Megakaryocytes | 3 | 1990 | 571 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2013 | 7148 | 0.010 |
Why?
|
Curriculum | 1 | 2014 | 3782 | 0.010 |
Why?
|
Reticulin | 2 | 1990 | 19 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 14752 | 0.010 |
Why?
|
Data Collection | 1 | 2009 | 3324 | 0.010 |
Why?
|
Research Design | 1 | 2015 | 6214 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2011 | 5544 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 30046 | 0.010 |
Why?
|
Logistic Models | 1 | 2011 | 13318 | 0.010 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2015 | 4640 | 0.010 |
Why?
|
Hospitalization | 1 | 2013 | 10847 | 0.010 |
Why?
|
Biopsy | 3 | 1989 | 6805 | 0.010 |
Why?
|
Collagen | 2 | 1990 | 2646 | 0.010 |
Why?
|
Hematopoiesis | 2 | 1989 | 2059 | 0.000 |
Why?
|
Osteosclerosis | 1 | 1989 | 41 | 0.000 |
Why?
|
Histocytochemistry | 1 | 1989 | 699 | 0.000 |
Why?
|
Platelet Count | 1 | 1988 | 787 | 0.000 |
Why?
|
Osteoblasts | 1 | 1989 | 1153 | 0.000 |
Why?
|
Spleen | 1 | 1989 | 2294 | 0.000 |
Why?
|
Cell Division | 1 | 1988 | 4478 | 0.000 |
Why?
|
Chronic Disease | 1 | 1988 | 9384 | 0.000 |
Why?
|